Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics
Main Authors: | Abdul Aziz, Mohd. Hafiz, Staatz, C.E., Kirkpatrick, C.M.J., Lipman, J., Roberts, J.A. |
---|---|
Format: | Article |
Language: | English |
Published: |
Minerva Medica
2012
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/22992/ http://irep.iium.edu.my/22992/ http://irep.iium.edu.my/22992/1/Continuous_infusion.pdf |
Similar Items
-
Continuous beta-lactam infusion in critically ill patients: the clinical evidence
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2012) -
The BLISS study: Beta-Lactam infusion in severe sepsis-randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015) -
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2016) -
The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2013) -
Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials
by: Roberts, Jason A., et al.
Published: (2016)